Xuan Marian Thai

Array ( [id] => 7741065 [patent_doc_number] => 08106166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-31 [patent_title] => 'Antibodies that bind specifically to phosphorylated β-catenin' [patent_app_type] => utility [patent_app_number] => 12/077290 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23293 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/106/08106166.pdf [firstpage_image] =>[orig_patent_app_number] => 12077290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792667 [patent_doc_number] => 20080293641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'BIOLOGICALLY ACTIVE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/049382 [patent_app_country] => US [patent_app_date] => 2008-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25538 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293641.pdf [firstpage_image] =>[orig_patent_app_number] => 12049382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458290 [patent_doc_number] => 20090258442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Reagents for the detection of protein phosphorylation in carcinoma signaling pathways' [patent_app_type] => utility [patent_app_number] => 12/074199 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 24792 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 52 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258442.pdf [firstpage_image] =>[orig_patent_app_number] => 12074199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422009 [patent_doc_number] => 20090148464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'PREVENTIVE OR THERAPEUTIC AGENT CONTAINING ANTI THIOREDOXIN ANTIBODY POLYPEPTIDE AS AN ACTIVE INGREDIENT FOR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/033295 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6261 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148464.pdf [firstpage_image] =>[orig_patent_app_number] => 12033295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575637 [patent_doc_number] => 20100047182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS' [patent_app_type] => utility [patent_app_number] => 12/527288 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15929 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047182.pdf [firstpage_image] =>[orig_patent_app_number] => 12527288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567577 [patent_doc_number] => 07847066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Antibody that binds uridine diphosphate' [patent_app_type] => utility [patent_app_number] => 12/029932 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23471 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/847/07847066.pdf [firstpage_image] =>[orig_patent_app_number] => 12029932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4567577 [patent_doc_number] => 07847066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Antibody that binds uridine diphosphate' [patent_app_type] => utility [patent_app_number] => 12/029932 [patent_app_country] => US [patent_app_date] => 2008-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23471 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/847/07847066.pdf [firstpage_image] =>[orig_patent_app_number] => 12029932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4609788 [patent_doc_number] => 07994293 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Antibodies specific for Dkk-1' [patent_app_type] => utility [patent_app_number] => 12/012885 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20511 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/994/07994293.pdf [firstpage_image] =>[orig_patent_app_number] => 12012885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4760191 [patent_doc_number] => 20080312417 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'UCP5' [patent_app_type] => utility [patent_app_number] => 12/012569 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22522 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312417.pdf [firstpage_image] =>[orig_patent_app_number] => 12012569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8592135 [patent_doc_number] => 08350012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Inverse agonist monoclonal antibody that suppresses thyrotropin receptor constitutive activity' [patent_app_type] => utility [patent_app_number] => 12/519513 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 13233 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12519513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515526 [patent_doc_number] => 08039598 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Met fab and SCFV fragments' [patent_app_type] => utility [patent_app_number] => 12/017274 [patent_app_country] => US [patent_app_date] => 2008-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 18131 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039598.pdf [firstpage_image] =>[orig_patent_app_number] => 12017274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342332 [patent_doc_number] => 20090180982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS' [patent_app_type] => utility [patent_app_number] => 11/970073 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16041 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20090180982.pdf [firstpage_image] =>[orig_patent_app_number] => 11970073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608391 [patent_doc_number] => 07993646 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'HK1-binding proteins' [patent_app_type] => utility [patent_app_number] => 11/956792 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 54306 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993646.pdf [firstpage_image] =>[orig_patent_app_number] => 11956792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764640 [patent_doc_number] => 20080175851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING THE GROWTH OF FISH AND SHELLFISH' [patent_app_type] => utility [patent_app_number] => 11/954113 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3290 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175851.pdf [firstpage_image] =>[orig_patent_app_number] => 11954113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765833 [patent_doc_number] => 20080177045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Monoclonal antibodies against ANGPTL3' [patent_app_type] => utility [patent_app_number] => 12/001012 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 36291 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20080177045.pdf [firstpage_image] =>[orig_patent_app_number] => 12001012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521415 [patent_doc_number] => 20090029396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Assay kit and antibody for human low molecular weight CD14' [patent_app_type] => utility [patent_app_number] => 11/987746 [patent_app_country] => US [patent_app_date] => 2007-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27987 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029396.pdf [firstpage_image] =>[orig_patent_app_number] => 11987746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4926976 [patent_doc_number] => 20080166339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Inhibition of osteopontin for treatment of relapsing autoimmune disease' [patent_app_type] => utility [patent_app_number] => 11/999099 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16161 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166339.pdf [firstpage_image] =>[orig_patent_app_number] => 11999099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4899861 [patent_doc_number] => 20080119475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Conjugates And Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/948656 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6115 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20080119475.pdf [firstpage_image] =>[orig_patent_app_number] => 11948656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903536 [patent_doc_number] => 20080112949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Optimized dosing with anti-CD4 antibodies for tolerance induction in primates' [patent_app_type] => utility [patent_app_number] => 11/998323 [patent_app_country] => US [patent_app_date] => 2007-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 21417 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112949.pdf [firstpage_image] =>[orig_patent_app_number] => 11998323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839371 [patent_doc_number] => 20080279856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Inhibition of Bradykinin Release' [patent_app_type] => utility [patent_app_number] => 11/940484 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16611 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279856.pdf [firstpage_image] =>[orig_patent_app_number] => 11940484 [rel_patent_id] =>[rel_patent_doc_number] =>)